Insider trades

Bain Capital Life Sciences Opportunities III, 10% Owner of Kyverna Therapeutics KYTX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/02/12.

Bain Capital Life Sciences Opportunities III

10% Owner
First filing
24/02/14
Trades
3 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
24/02/12

Trading activity

Transactions

Trade type
Open-market buy24/02/1224/02/14450,000 sh$22.00$9,900,000+16.6%